Volato Announces Changes to Board Composition
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Boston Scientific (BSX) PT Raised to $77 at Oppenheimer
April 25, 2024 10:00 AM EDTOppenheimer analyst Steven Lichtman raised the price target on Boston Scientific (NYSE: BSX) to $77.00 (from $68.00) while maintaining a Outperform rating.
The analyst comments "BSX delivered 1Q24 sales meaningfully ahead of the Street (13% organic y/y). EPS was also beat ($0.56 versus our/Street's... More
Boston Scientific (BSX) PT Raised to $82 at RBC Capital
April 25, 2024 6:40 AM EDTRBC Capital analyst Shagun Singh raised the price target on Boston Scientific (NYSE: BSX) to $82.00 (from $78.00) while maintaining a Outperform rating.
The analyst comments "BSX delivered solid beat with an upside surprise of ~5% and ~10% on sales and EPS, respectively. Given this momentum (+660bps... More
Boston Scientific (BSX) PT Raised to $82 at Wells Fargo
April 25, 2024 5:23 AM EDTWells Fargo analyst Lawrence Biegelsen raised the price target on Boston Scientific (NYSE: BSX) to $82.00 (from $72.00) while maintaining a Overweight rating.
The analyst comments "Today (4/24), BSX reported Q1 rev/EPS ahead of Street and raised 2024 rev guidance by 250bps at the mdpt to 10-12%.... More
Boston Scientific (BSX) PT Raised to $80 at BTIG
April 24, 2024 3:14 PM EDTBTIG analyst Marie Thibault raised the price target on Boston Scientific (NYSE: BSX) to $80.00 (from $74.00) while maintaining a Buy rating.
The analyst comments "After a record-setting 2023, Boston Scientific is starting 2024 at an even faster pace. BSX reported Q1 revenue of $3.856B (+13.8% y/y rep., +13.1% org.) and adj. EPS of $0.56 (consensus $3.684B and $0.51), well above its guidance... More
Boston Scientific (BSX) pipeline strength fuels quarterly earnings beat
April 24, 2024 6:47 AM EDTBoston Scientific (NYSE: BSX) reported a significant earnings and revenue beat for the first quarter of 2024, exceeding analyst expectations and providing an optimistic outlook for the future. The company's shares rose by 2.7% as the market responded positively to the news.
The medical device maker announced an adjusted EPS of $0.56, surpassing the consensus estimate of $0.51. Revenue for the quarter was also higher than anticipated, coming in at $3.86 billion against the expected $3.68 billion. These figures... More
